KULICKE AND SOFFA INDUSTRIES, INC. (KLIC): what the price assumes
In the published model solve dated 2026-Q2, anchored at $82.13, KULICKE AND SOFFA INDUSTRIES, INC. (KLIC) is priced for today's economics sustained for ~13.4 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.
Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/KLIC
Headline
| Field | Value |
|---|---|
| Ticker | KLIC |
| Company | KULICKE AND SOFFA INDUSTRIES, INC. |
| Current price | $82.13/sh |
| Composition | General Semiconductor 51% / Automotive & Industrial 17% / Memory 8% / APS 24% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin (value-band context) | 34.2% |
| Operating margin (mid-cycle) | 13.8% |
| Margin expansion (value-band) | +20.4pp |
| Trailing margin (depressed year) | 6.7% |
| Must persist for | 13.4y |
| Multiple paid | 39x mid-cycle operating income |
The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.
Solve inputs: computed at a 11.9% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.2 years.
Reconcile: at the x-ray's 9.3% required return this reads ~8 years; the models below use their own rates.
How unusual the bet is: elevated
| Reference | Value |
|---|---|
| vs own history | +0.16σ |
| cohort percentile (of 190 peers) | 67 |
| sustained it ~10 years at this level | 15% |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 8.96x | 5 | expensive |
| Earnings | 7.14x | 3 | expensive |
| Relative | 1.89x | 3 | expensive |
| Growth | 1.09x | 3 | expensive |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.
Per-Model Detail (n=14)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $6.00 | 13.69x | yes | FCF base $0.0B, growth 12% (input: historical growth), terminal g 4.0%, WACC 9.0%, 6yr projection |
| DCF Exit Multiple | Growth | $76.15 | 1.08x | yes | Exit EV/EBITDA: 59.2x / 61.2x / 63.2x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $43.55 | 1.89x | yes | P/E 39.18x (blended: static sector reference 22x + trailing (TTM) 79x), scenarios: 32.3x / 39.2x / 46.1x (bear / base = reference held flat / bull), EV/EBITDA 29.57x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $11.20 | 7.33x | yes | BV/sh $16.14, ROE (TTM) 6.4%, ke 9.3% |
| Two-Stage Excess Return | Asset | $9.17 | 8.96x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $75.28 | 1.09x | yes | Rev $0.8B, growth 12% (input: historical growth; tapered), Terminal P/S: 4.7x / 5.7x / 6.7x (bear / base = today's held flat / bull, cap 12x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $36.61 | 2.24x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.19B × (1−17%) / WACC 9.0% → EPV (no growth) |
| Residual Income | Asset | $8.90 | 9.23x | yes | BV $16.14 + 5yr PV of (ROE (TTM) 6.4% − Kₑ 9.3%) × BV; BV grows 4.2%/yr |
| Graham Number | Asset | $19.66 | 4.18x | yes | √(22.5 × EPS $1.06 × BVPS $16.14) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $24.29 | 3.38x | yes | EBITDA $0.07B × sector EV/EBITDA 16.0x |
| FCF Yield | Earnings | $4.70 | 17.47x | yes | FCF $4.3M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $0.89 | 92.28x | yes | EPS $1.06 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median) |
| ROIC-Justified P/B | Asset | $8.77 | 9.36x | yes | BV $16.14 × (ROIC 4.9% / WACC 9.0%) |
| P/Sales Sector | Relative | $72.31 | 1.14x | yes | Revenue $0.77B × sector P/S 5.0x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $11.50 | 7.14x | yes | EPS $1.06 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $487.9m |
| Net debt / NOPAT (after-tax) | -5.58x (net cash) |
| Net debt / operating income (pre-tax) | -4.62x (net cash) |
| Interest coverage | 714.2x |
| Share count CAGR (buyback) | -4.0% |
| Burning cash | no |
Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 13.8%); the trailing year was depressed.
Bullet Takeaways
At $121.81 the market pays roughly 60x company-wide mid-cycle operating income for Kulicke & Soffa, an assumption that operating growth holds near its self-funding ceiling for about 19 years. Only about 15% of comparable fast-growers have sustained that pace for even a decade.
The balance sheet is the firm's strongest card: nearly $488 million in cash and investments, no debt, and a share count shrinking about 4% a year through buybacks. That cushion funds the recovery and the pivot to advanced-packaging bonding without a capital raise.
Fiscal Q2 2026 revenue jumped 21.5% sequentially to $242.6 million with adjusted EPS of $0.79 beating expectations, and management guided Q3 to about $310 million. The business is recovering off a deep cyclical trough, but the static valuation methods say the price has run far ahead of the earnings.
Bull Case
The clearest thing about Kulicke & Soffa is its balance sheet, and that balance sheet is the bull case. The company holds nearly $488 million in cash and investments against essentially no debt, with interest coverage that is academic because there is almost nothing to cover. That is an unusually strong balance sheet for a sub-$1-billion-revenue equipment maker, and what it reveals is management confidence: a board that keeps buying back stock, having repurchased shares under successive programs and authorized a new one (FY2025 10-K, accession 0000056978-25-000081), and that is funding a capacity expansion out of cash rather than dilution. The share count has shrunk about 4% a year, the cleanest possible signal that insiders think the stock is worth owning through the cycle.
That cash matters because it buys time to ride a recovery that is clearly underway. Fiscal Q2 2026 revenue rose 21.5% sequentially to $242.6 million, GAAP net income swung to $35.1 million from a year-earlier loss, and adjusted EPS of $0.79 beat the $0.67 expectation. The bookings line in the filing tells the trajectory: orders of $750.8 million in fiscal 2025 versus $431.0 million the year before, with backlog up to $245.3 million from $148.6 million (FY2025 10-K). The memory segment alone jumped 93% sequentially on NAND demand and expansion among Chinese memory packagers. A company with this much net cash does not have to chase the cycle; it can invest into it from strength.
The forward option is the advanced-packaging pivot, and management is funding it deliberately. Kulicke & Soffa is raising fiscal 2026 capex from about $12 million to $22 million to expand thermo-compression bonding capacity, targeting roughly $400 million in annual TCB system sales by early fiscal 2027, while winding down its lower-return Electronics Assembly business. TCB is the bonding technology that AI accelerators and high-bandwidth memory increasingly require, the same advanced-packaging wave lifting the whole equipment sector. Against peers like FormFactor, Allegro, and Skyworks, Kulicke & Soffa is a focused, debt-free, cash-rich way to play the packaging step, with the financial room to keep investing if the recovery extends. The balance sheet is what lets the growth story stay credible.
Bear Case
The variable with the most leverage on Kulicke & Soffa is geopolitics, and the price does not reflect that exposure. A large share of demand for ball-bonding equipment flows through Chinese assembly and test houses, the OSATs that package chips, and the company's own filing flags the Chinese government as a competitive and policy risk alongside its note that average selling prices usually decline over time due to continuous price pressure from customers, competitors, and supply-chain cost reductions (FY2025 10-K, accession 0000056978-25-000081). That is a double bind: the fastest-growing slice of demand sits in the jurisdiction most exposed to export controls and trade friction, and the pricing on the equipment erodes structurally even when units grow. A tightening of US controls on bonding equipment to China, or Chinese retaliation favoring domestic suppliers, would remove demand that may not return.
The macro cyclicality is the second exposure, and it is severe. The company states plainly that the semiconductor industry is volatile and that its operating results are adversely impacted by volatile worldwide economic conditions (FY2025 10-K). The numbers prove it: bookings nearly doubled from $431 million to $751 million in a single year, the kind of swing that runs in both directions. The recovery the bull case celebrates is the up-leg of a cycle that has a down-leg, and equipment orders can evaporate as fast as they appeared when end demand softens or customers digest capacity.
What makes those risks acute is the valuation. At $121.81 (June 27, 2026) the price embeds operating growth held near the self-funding ceiling for roughly 19 years, a duration the reverse-DCF flags as elevated, above what fundamentals comfortably support, with only about 15% of comparable fast-growers sustaining such a pace for even ten years. The asset and earnings-power methods land in the teens to low thirties; only the growth-DCF reaches the price, and it does so by extrapolating a cyclical peak. Net cash near $488 million protects the company from insolvency, but it does not protect the stock from a re-rating if the China door narrows or the cycle rolls. Buy here and you are paying a near-two-decade growth premium for a small, cyclical, China-exposed equipment maker. That is the fragility the price ignores.
Valuation
Kulicke & Soffa is the textbook case of method disagreement, and the disagreement says the price is stretched. Every static frame that values the company on what it owns or earns today lands far below $121.81: simple excess return near $11, two-stage excess return near $9, residual income near $9, the Graham Number near $20, and earnings power value near $36 even after normalizing a five-year average EBIT. Those reflect a trailing return on equity near 6% and a book value per share of $16.14. The only methods that reach the price are the growth and relative frames, the DCF exit multiple and discounted future market cap near $112, the blended relative method near $52, and they do so by extrapolating recent cyclical growth and a peak multiple.
The reverse-DCF makes the stretch explicit. Because trailing earnings are depressed by the cycle, the engine prices the company on its through-the-cycle margins, normalized operating income near $106 million on a 13.8% mid-cycle margin, and at $121.81 the market pays roughly 60x that figure. That implies operating growth held near the 25% self-funding ceiling for about 19 years, computed at a 12.4% cost of capital, with each percentage point of growth shifting the required duration by about 2.7 years.
The honest synthesis is that on normalized, through-the-cycle economics, the stock looks expensive, and the priced-in assumption is elevated rather than merely demanding. The bull case is not that the methods are wrong but that they cannot price a successful pivot to advanced-packaging TCB, the durable-compounding bet only the growth frame captures. The balance sheet, nearly $488 million of net cash and no debt, removes the downside-insolvency risk and gives the pivot room to play out. But the math is unambiguous: the price requires the recovery to become a long secular growth story, not just a cyclical bounce, and the base rate for sustaining that is low.
Catalysts
Fiscal Q2 2026 (reported spring 2026) was a strong recovery quarter: net revenue of $242.6 million, up 21.5% sequentially, GAAP net income of $35.1 million versus a year-earlier loss, and adjusted EPS of $0.79 against a $0.67 expectation. The memory segment rose 93% sequentially on NAND demand and Chinese memory-packager expansion. Management guided fiscal Q3 to about $310 million in revenue, plus or minus $20 million, with non-GAAP EPS near $1.00, a sharp sequential step up that the next print will have to validate.
The defining strategic catalyst is the advanced-packaging pivot. Kulicke & Soffa is raising fiscal 2026 capex from about $12 million to $22 million to expand thermo-compression bonding capacity and targets roughly $400 million in annual TCB system sales by early fiscal 2027, while winding down its Electronics Assembly business. Milestones on TCB design wins, capacity, and the path to that $400 million run-rate will drive the growth thesis directly over the coming quarters.
The swing factors to watch over the next 90 days are China export-control policy, since a large share of ball-bonding demand flows through Chinese assembly houses, the booking trend as a leading indicator of the cycle, and continued share buybacks against the nearly $488 million cash balance. End-market demand from AI-driven advanced packaging versus traditional commodity packaging is the mix question that determines whether the recovery is cyclical or secular.
Sources: PRNewswire (KLIC Q2 2026 results), StockTitan (Q2 2026 8-K), Yahoo Finance (Q2 2026 call), Investing.com (Q2 FY2026 slides), Quartr, StockAnalysis.
Peer Cohorts (Per Segment, With Filing Citations)
Ball Bonding Equipment (reported)
- ONTO (ONTO INNOVATION INC.)
- FY2025 10-K: …to complex measurement and process problems. We believe that customer service and technical support for our systems are crucial factors that distinguish us from our competitors and are essential to building and maintaining close, long-term relationships with our customers. We generally provide a warranty for our…
- FY2025 10-K: …manufacturers around the world. It is our strategy to outsource the assemblies that do not contain elements that we believe lead to a direct competitive advantage. Most of our automated and integrated products are currently manufactured at our Milpitas and Bloomington facilities. We currently do not expect our…
- NVMI (NOVA LTD.)
- FY2025 20-F: …in China. The recent acquisition of Sentronics and the expansion of our portfolio in the wafer level packaging and specialty markets, positions us in direct competition with companies such as Merck and Camtek. Some of our competitors have greater financial, engineering, manufacturing and marketing resources than we…
- FY2025 20-F: …for both dimensions and materials. This provides the most advanced portfolio, combining the best innovative metrology capabilities with the best reliability and return on investment. • The ability to provide a unique and differentiated technology portfolio sets us apart from the competition and adds a competitive…
- CAMT (CAMTEK LTD)
- (no filing in the citation store)
- ACLS (AXCELIS TECHNOLOGIES INC)
- FY2025 10-K: …the U.S. dollar. We may not be able to maintain and expand our business if we are not able to hire, retain and integrate qualified personnel. Our business depends on our ability to attract and retain qualified, experienced employees. There is substantial competition for experienced engineering, technical,…
- FY2025 10-K: …of being distinct, whereby the customer can benefit from the good or service either on its own or together with other available resources, and are distinct in the context of the contract, whereby the transfer of the good or service is separately identifiable from other promises in the contract. To the extent a…
- COHU (COHU INC)
- FY2025 10-K: …solutions, and software analytics to optimize semiconductor manufacturing yield and productivity. We offer a comprehensive suite of equipment, interface solutions, software, spares and services designed to address the evolving requirements of global semiconductor manufacturers. Our products support customers across…
- FY2025 10-K: …relatively small in terms of worldwide market size compared to other segments of the semiconductor equipment industry, has several participants resulting in intense competitive pricing pressures. In addition, there are emerging companies that provide or may provide innovative technology incorporated in products that…
- VECO (VEECO INSTRUMENTS INC.)
- FY2025 10-K: …for EUV lithography. Our IBD300 system is being evaluated for 300mm front end semiconductor applications where low resistivity metals like tungsten, ruthenium and molybdenum are critical. The IBD systems are also critical in the manufacture of hard disk drive magnetic heads where they are used to deposit various…
- FY2025 10-K: Laser Annealing Systems Our laser annealing systems meet the industry demand for ultra-short time-scale "millisecond" annealing, heating the wafer up to temperatures just below the silicon melting point, enabling thermal annealing solutions at the most advanced semiconductor process nodes. This unique annealing…
- AEHR (AEHR TEST SYSTEMS)
- FY2025 10-K: …lot of devices. The unique design accommodates a wide range of socket sizes and densities so that the DiePak Carrier technology can evolve along with the changing requirements of the customer's devices. The DiePak Carriers are custom designed for each device type, each of which has a typical lifetime of two to seven…
- FY2025 10-K: …loading of the customer's modules to the DiePak Carrier so that the modules can be tested and burned-in by the FOX-XP and FOX-NP system. Typically, one DiePak Loader can support several FOX-XP or FOX-NP systems. Net revenues of full wafer contact product lines, systems, WaferPak Contactors, DiePak Carriers and…
Wedge Bonding Equipment (reported)
- ONTO (ONTO INNOVATION INC.)
- FY2025 10-K: …to complex measurement and process problems. We believe that customer service and technical support for our systems are crucial factors that distinguish us from our competitors and are essential to building and maintaining close, long-term relationships with our customers. We generally provide a warranty for our…
- FY2025 10-K: …manufacturers around the world. It is our strategy to outsource the assemblies that do not contain elements that we believe lead to a direct competitive advantage. Most of our automated and integrated products are currently manufactured at our Milpitas and Bloomington facilities. We currently do not expect our…
- NVMI (NOVA LTD.)
- FY2025 20-F: …manufactures to overcome new challenges in dimensions, materials and chemical engineering. The Semiconductor Market - Update According to Gartner forecasts, semiconductor revenues are expected to grow by 33% in 2026, following a growth of 21% in 2025. WFE (Wafer Fab Equipment) is expected to grow by 12% in 2026,…
- FY2025 20-F: , Mr. Waisman was granted with 5,930 performance-based restricted units that vest over a period of four (4) years, in four equal annual installments, provided with respect to 50% of the units, the Company meets or exceeds the revenue budget as set forth in the Company's budget as approved by the board of directors for…
- CAMT (CAMTEK LTD)
- (no filing in the citation store)
- ACLS (AXCELIS TECHNOLOGIES INC)
- FY2025 10-K: …and other challenges reflecting China's stage of development and rapid growth. Increased U.S. export controls and other political and trade tensions exacerbate the risk that Chinese customers will change suppliers to non-U.S. vendors, such as Advanced Ion Beam Technology, Inc., Nissin Ion Equipment Co., Ltd. and…
- FY2025 10-K: …ensure our products meet the needs of our customers. We take pride in our scientists and engineers who are adding to our portfolio of patents and proprietary technology to ensure that our investment in technology leadership translates into unique product advantages. We strive for operational excellence by focusing on…
- COHU (COHU INC)
- FY2025 10-K: …solutions, and software analytics to optimize semiconductor manufacturing yield and productivity. We offer a comprehensive suite of equipment, interface solutions, software, spares and services designed to address the evolving requirements of global semiconductor manufacturers. Our products support customers across…
- FY2025 10-K: …relatively small in terms of worldwide market size compared to other segments of the semiconductor equipment industry, has several participants resulting in intense competitive pricing pressures. In addition, there are emerging companies that provide or may provide innovative technology incorporated in products that…
- VECO (VEECO INSTRUMENTS INC.)
- FY2025 10-K: …for EUV lithography. Our IBD300 system is being evaluated for 300mm front end semiconductor applications where low resistivity metals like tungsten, ruthenium and molybdenum are critical. The IBD systems are also critical in the manufacture of hard disk drive magnetic heads where they are used to deposit various…
- FY2025 10-K: Laser Annealing Systems Our laser annealing systems meet the industry demand for ultra-short time-scale "millisecond" annealing, heating the wafer up to temperatures just below the silicon melting point, enabling thermal annealing solutions at the most advanced semiconductor process nodes. This unique annealing…
Advanced Solutions (reported)
- ONTO (ONTO INNOVATION INC.)
- FY2025 10-K: …into our lithography systems to meet our customers' changing process requirements. Our metrology and inspection technologies provide process control for the majority of advanced node wafers processed today in a semiconductor wafer fab. In front-end processes, OCD metrology, thin film metrology, wafer stress metrology…
- FY2025 10-K: …wafers to improve device performance and manufacturing yields. Our end customers manufacture many types of ICs for a multitude of applications, each having unique manufacturing challenges. This includes ICs to enable information processing and management (logic ICs), memory storage (NAND, 3D-NAND, and DRAM), analog…
- NVMI (NOVA LTD.)
- FY2025 20-F: …for both dimensions and materials. This provides the most advanced portfolio, combining the best innovative metrology capabilities with the best reliability and return on investment. • The ability to provide a unique and differentiated technology portfolio sets us apart from the competition and adds a competitive…
- FY2025 20-F: …for advanced applications, which require dimensional, material and chemical metrology. • Grow our production facilities and offices footprint to meet semiconductor demand and our strategic plans and continue to develop modern and streamlined core business processes through new ERP and Service CRM infrastructure. •…
- CAMT (CAMTEK LTD)
- (no filing in the citation store)
- VECO (VEECO INSTRUMENTS INC.)
- FY2025 10-K: Laser Annealing Systems Our laser annealing systems meet the industry demand for ultra-short time-scale "millisecond" annealing, heating the wafer up to temperatures just below the silicon melting point, enabling thermal annealing solutions at the most advanced semiconductor process nodes. This unique annealing…
- FY2025 10-K: …for EUV lithography. Our IBD300 system is being evaluated for 300mm front end semiconductor applications where low resistivity metals like tungsten, ruthenium and molybdenum are critical. The IBD systems are also critical in the manufacture of hard disk drive magnetic heads where they are used to deposit various…
- COHU (COHU INC)
- FY2025 10-K: …solutions, and software analytics to optimize semiconductor manufacturing yield and productivity. We offer a comprehensive suite of equipment, interface solutions, software, spares and services designed to address the evolving requirements of global semiconductor manufacturers. Our products support customers across…
- FY2025 10-K: …evolving technical challenges. These investments, spanning AI-enabled analytics, high-precision inspection and metrology, advanced thermal control, and intelligent automation, expand our serviceable available market ("SAM") to approximately $3 billion and strengthen our competitive differentiation in high-complexity…
- ACLS (AXCELIS TECHNOLOGIES INC)
- FY2025 10-K: …products and enhancements. Our Beverly, Massachusetts Advanced Technology Center houses a process development laboratory with a 13,500 square feet class 10/100/1000 clean room for product demonstrations and process development and a 17,500 square feet customer training center. The Advanced Technology Center provides…
- FY2025 10-K: …sites in key market segments. ● We continued our investment in our Customer Solutions & Innovation ("CS&I") aftermarket business to drive financial growth and increased customer satisfaction levels, including the "Digital Tool Box," an innovative service offering with online training, remote diagnosis and install,…
APS (reported)
- COHU (COHU INC)
- FY2025 10-K: …to settle PSUs granted ranges from 0 % to 200 % of the number granted and is determined based on certain performance criteria over a three-year measurement period. The performance criteria for the majority of PSUs are based on a combination of our annualized Total Shareholder Return ("TSR") for the performance period…
- FY2025 10-K: …grants under the 2005 Plan and 353,581 shares available for purchase under the ESPP. Employee Stock Purchase Plan The ESPP provides for the issuance of a maximum of 3,750,000 shares of our common stock. Under the ESPP, eligible employees may purchase shares of common stock through payroll deductions. The price paid…
- UCTT (Ultra Clean Holdings, Inc.)
- FY2025 10-K: …the total number of PSUs earned, if any, reflects the application of the performance formula to the target award, subject to a maximum payout cap of 200 % of the target PSUs granted. Earned PSUs vest and are settled in shares of the Company's common stock in accordance with the terms of the applicable award…
- FY2025 10-K: …no unamortized expense related to the Company's unvested RSAs as of December 26, 2025. Employee Stock Purchase Plan The ESPP permits employees to purchase common stock at a discount through payroll withholdings at certain specified dates (purchase period) within a defined offering period. The purchase price is 85 %…
- ICHR (Ichor Holdings, Ltd.)
- FY2025 10-K: …sales. Additional focus is being placed on expanding our engagement in this industry as a source for future revenue growth. Our sales and marketing efforts focus on fostering close business relationships with our customers. As a result, we locate many of our account managers near the customers they support. Our sales…
- FY2025 10-K: …devote greater resources to the development, promotion, sale and support of their products and services, and reduce prices to increase market share. In addition to organic growth by our competitors, there may be merger and acquisition activity among our competitors and potential competitors that may provide our…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.